Skip to content

Released Nov 8, 2016, before the open

10-Q filed Nov 8, 2016, 39 days after period end · 0001144204-16-132256

Q3 2016 · 10-Q
Revenue—
Net Income-$3.24MN/M vs Q3 2015N/M vs Q2 2016
EPS Diluted-$0.18N/M vs Q3 2015N/M vs Q2 2016
Operating Income-$3,286,220N/M
Operating Cash Flowderived-$4,049,532N/M
Free Cash Flowderived-$4,049,532N/M

What the release said

The release

Same quarter

MetricQ3 2016Q3 2015Q3 2014Q3 2013
Revenue———$0.00
Net Income-$3.24M-$6.37M-$4.09M-$3.48M
EPS Diluted-$0.18-$0.35-$0.32-$0.39

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR